Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
domenica, ottobre 25
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
CryoPort Inc
CYRX
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$17.98
0.15
0.84%
Ult. Agg.: Oct 23, 4:00 PM
Get Report
Panoramica
Notizie
Previsioni utili
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Utili:
I risultati di Q3 2026 tra 11 giorni da adesso in gio nov 5th, dopo la chiusura del mercato
CryoPort Financials
CryoPort (CYRX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Conference Call: CryoPort Affirms FY2026 Sales Guidance of $192.000M-$196.000M vs $194.390M Est
CryoPort (NASDAQ:CYRX) affirms FY2026 sales outlook from $192.000 million-$196.000 million to $192.000 million-$196.000 million vs $194.390 million estimate.
Benzinga Newsdesk
PRO
CryoPort Q2 Adj. EPS $(0.20) Misses $(0.19) Estimate, Sales $48.971M Beat $48.207M Estimate
CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.19) by 5.26 percent. This is a 16.67 percent increase over losses of $(0.24) per share from the
Benzinga Newsdesk
Cryoport Posts Revenue Beat In Q1 As Clinical Trial Support Hits All-Time High — 'A Strong Start To 2026'
Cryoport released financial results for Q1 of fiscal 2026 Monday after the closing bell.
Henry Khederian
PRO
CryoPort Raises FY2026 Sales Guidance from $190.000M-$194.000M to $192.000M-$196.000M vs $191.834M Est
CryoPort (NASDAQ:CYRX) raises FY2026 sales outlook from $190.000 million-$194.000 million to $192.000 million-$196.000 million vs $191.834 million estimate.
Benzinga Newsdesk
PRO
CryoPort Q1 Adj. EPS $(0.25) Misses $(0.22) Estimate, Sales $47.800M Beat $44.862M Estimate
CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.22) by 13.64 percent. This is a 10.71 percent increase over losses of $(0.28) per share from the
Benzinga Newsdesk
Earnings Scheduled For May 4, 2026
Benzinga Insights
